Image Source: Unsplash

Hypera SA is known by the trading ticker symbol, HYPMY. It is listed in the Healthcare sector as a Specialty and Generic Drug Manufacturing Company. This is my first-ever report on Hypera SA for my Vista stock Portfolio or any of my previous collections.

Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the major pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure.

It sells its products through distributors and wholesalers. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. 

Hypera S.A. was founded in 2001 and is headquartered in São Paulo, Brazil.

Three key data points gauge dividend equities or funds like Hypera SA :

(1) Price

(2) Dividends

(3) Returns

Those three basic keys best tell whether any company has made, is making, and will make money. 

HYPMY Price

Hypera's price per share was $6.86 as of yesterday's market close. One year ago its price was $6.16. So HYPMY's share price has increased about 11.4% in the past year. 

If Hypera stock trades in the range of $4.50 to $8.00 this next year, its recent $6.86 price might rise by $0.74 to reach $7.60 by August 13, 2022. My estimate is $0.04 under the one-year price upside recorded over the past year.

HYPMY Dividends

Hypera's most recent regular quarterly dividend payout of  $0.612  was declared July 6th and projected an annual payout of $0.24 to yield 3.57% based on yesterday's $6.86 closing price. HYPMY has paid variable quarterly dividends for 5 years.

HYPMY Returns

Adding the $0.24 annual HYPMY forward-looking dividend to my $0.74 price upside estimate shows a $0.98 potential gross gain, per share, to be reduced by any costs to trade HYPMY shares.  

At yesterday's $6.86 price per share, a little over $1000 would buy 146 shares.

A $10 broker fee (if charged) would be paid half at purchase and half at a sale and might cost us about $0.07 per share.

Subtract that maybe $0.07 brokerage cost from my estimated $0.98 gross gain per share results in a net gain of $0.91 X 146 shares = $132.86 for a 13.28% net gain on a $1,001.56 investment.

So it is that Hypera SA shows a possible 13.28% net gain including a 3.57% forward estimated dividend yield. 

Over the next year at this time, a $1000 investment in Hypera SA could generate $35.70 in cash dividends alone. And a single share bought at yesterday's closing price was $6.86! Thus, HYPMY's share price is now about 19% of the dividend income from $1K invested. So, according to my dividend dogcatcher ideal, this is a good time to pick up Hypera SA shares because the dividend from $1k invested exceeds the single share price by a little over five times. Consider yourself alerted.  

All of the estimates above are speculation based on the past history of Hypera SA. Only time and money invested in this stock will determine its market value.